AU2788397A - Ophthalmovascular blood flow ameliorants and optic papilla protectives - Google Patents

Ophthalmovascular blood flow ameliorants and optic papilla protectives

Info

Publication number
AU2788397A
AU2788397A AU27883/97A AU2788397A AU2788397A AU 2788397 A AU2788397 A AU 2788397A AU 27883/97 A AU27883/97 A AU 27883/97A AU 2788397 A AU2788397 A AU 2788397A AU 2788397 A AU2788397 A AU 2788397A
Authority
AU
Australia
Prior art keywords
ophthalmovascular
ameliorants
protectives
blood flow
optic papilla
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27883/97A
Inventor
Shigeki Fujisawa
Hisashi Shinohara
Yasuhiro Takeji
Hiroki Urashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of AU2788397A publication Critical patent/AU2788397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU27883/97A 1996-05-27 1997-05-14 Ophthalmovascular blood flow ameliorants and optic papilla protectives Abandoned AU2788397A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP8-131553 1996-05-27
JP13155396 1996-05-27
JP16304496 1996-06-24
JP8-163044 1996-06-24
PCT/JP1997/001621 WO1997045118A1 (en) 1996-05-27 1997-05-14 Ophthalmovascular blood flow ameliorants and optic papilla protectives

Publications (1)

Publication Number Publication Date
AU2788397A true AU2788397A (en) 1998-01-05

Family

ID=26466366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27883/97A Abandoned AU2788397A (en) 1996-05-27 1997-05-14 Ophthalmovascular blood flow ameliorants and optic papilla protectives

Country Status (2)

Country Link
AU (1) AU2788397A (en)
WO (1) WO1997045118A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120861A (en) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd Dihydropyridine derivative
JPS6137765A (en) * 1984-07-19 1986-02-22 サンド・アクチエンゲゼルシヤフト 3_aminopropoxyaryl derivative
AU4246793A (en) * 1992-05-13 1993-12-13 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents

Also Published As

Publication number Publication date
WO1997045118A1 (en) 1997-12-04

Similar Documents

Publication Publication Date Title
AU4255497A (en) System and method for improving vascular blood flow
AU5132699A (en) Catheter having flow diffusing tip
AU2473995A (en) Occludable catheter
AU2000235821A1 (en) Integrated pump and cannula systems and related methods
EP0778033A3 (en) Blood treatment device with balanced flow
AU2390000A (en) Rheological treatment methods and related apheresis systems
AU4550299A (en) Reversing flow blood processing system
AU3790399A (en) Blood set and chamber
AU6688398A (en) Intravascular aspiration system
AU2777495A (en) Endoscopic vascular clamping system and method
AU3955795A (en) Biocompatible coating, medical device using the same and methods
AU4139596A (en) Surgical fluid and blood loss monitor
AU3971797A (en) Blood aspirator
AU3378297A (en) Blood treatment system
EP0745396A3 (en) Blood pump and application thereof
AU2769697A (en) Benzofuryl derivatives and their use
AU6266798A (en) Disposable multi-sampler and fitment
AU3357597A (en) Skin blood flow measurement
AU4069395A (en) Optically active benzothiepin derivative, its preparation and use
AU7274598A (en) Light delivery catheter and method for the use thereof
AU4480697A (en) Human nm23-like protein
AU4593397A (en) Two human cathepsin proteins
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
EP1057492B8 (en) Blood-compatible composition and medical device using same
AU2407797A (en) Sulfamoyltriazole derivatives and agricultural and horticultural bactericides